Navigation Links
Gardasil Refused Subsidy

Cervical cancer vaccine, a world-first vaccine which has been shown to prevent 70 per cent of cervical cancers has been removed //from the national immunisation program, according to reports from Labor today.

The government's pharmaceutical advisory body has rejected an application today from Australian manufacturer CSL to make the vaccine Gardasil freely available to all females between ages 12 and 26.

Gardasil, the vaccine designed in Australia halts the spread of sexually-transmitted human papilloma virus (HPV), which causes 70 per cent of cervical cancer.

The NSW Cancer Council has estimated that around 700 Australian women are diagnosed with cervical cancer each year causing about 270 deaths.

Although the vaccine has been on the market for two months it costs $460 for patients to take the recommended three doses.

Only last week the Pharmaceutical Benefits Advisory Committee (PBAC) considered a subsidy for the drug at its regular meeting in Canberra.

CSL and Professor Ian Frazer, who was named Australian of the Year 2006 for designing the vaccine, have been informed today it had been knocked back due to its high price.


NLA
'"/>




Page: 1

Related medicine news :

1. Gardasil vaccine for cervical cancer
2. Gardasil- Cervical Cancer Vaccine Now Approved
3. Gardasil, a cervical cancer vaccine, hits the market
4. Gardasil Hailed as one of the Biggest Research Successes
5. Cervical Cancer Vaccine Gardasil Included In Subsidized CDC program
6. School Vaccination Program to Include Cancer Drug Gardasil
7. Developing Nations to Get Gardasil at Lesser Rates from Merck Soon
8. Gardasil – Cervical Cancer Vaccine in UA
9. Acid Test - Glaxos Cervarix, and Mercks Gardasil, Compete
10. Smoker Refused Treatment
11. Boy Refused Compensation For HIV Infection Following Hospital Admission
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... Viejo, CA (PRWEB) , ... April 28, 2016 , ... ... use within Final Cut Pro X . With ProText Layouts, video editors ... tweak animations to match the length and scale of texts. Creating text-based videos ...
(Date:4/28/2016)... ... , ... Head Over Heels Athletic Arts’ gymnast, Brooklyn Varize, has qualified to ... at the University of Montana on April 28-May 1. Varize will compete on Saturday ... order to qualify, Varize needed to place top seven all-around in her respective age ...
(Date:4/28/2016)... ... April 28, 2016 , ... The ... successful events, attracting medical professionals from around the globe who attended a week’s ... Opening Ceremonies Sunday, April 17 included the introduction of the 2016 ARRS Distinguished ...
(Date:4/28/2016)... ... April 28, 2016 , ... Greener Hydroponics is now offering a ... frequently used by professional organic farmers and nurseries according to Sales Manager Joe Steele ... fabric pots. Our goal is to offer wholesale level pricing and ultra-fast shipping for ...
(Date:4/28/2016)... ... April 28, 2016 , ... Horizon ... collaborating with doctors and hospitals to make transformative changes in how health care ... therapy minds this week in discussing breakthroughs in cellular medicine to treat disease. ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 Oramed ... a clinical-stage pharmaceutical company focused on the development of oral ... in the upcoming PIONEERS 2016 conference, presented by Joseph ... 2016 in New York . Nadav ... at the conference. Presentation Details:   ...
(Date:4/28/2016)... Florida , April 28, 2016 ... the development of innovative peptide and gene-based immunotherapeutics and vaccines ... it will be presenting at the 3rd Annual Growth ... - 5 th , 2016 at Caesars Palace in Las Vegas, ... 8.00 am on Wednesday, May 4 th by Dr. ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 ... Sachs CEO Forums in Zürich gab Strekin ... führenden Wirkstoffkandidaten STR001 zur Erhaltung des Resthörvermögens ... wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie mit ... Frankreich angeworben. STR001 wird während der Operation ...
Breaking Medicine Technology: